USANA Health Sciences (USNA) Competitors

USANA Health Sciences logo
$12.98 -0.18 (-1.38%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$13.25 +0.27 (+2.10%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

USNA vs. BWMX, HNST, PRE, NUS, and NATR

Should you buy USANA Health Sciences stock or one of its competitors? USANA Health Sciences's main competitors and comparable companies include Betterware de Mexico SAPI de C (BWMX), Honest (HNST), Prenetics Global (PRE), Nu Skin Enterprises (NUS), and Nature's Sunshine Products (NATR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Betterware de Mexico SAPI de C (NYSE:BWMX) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

Betterware de Mexico SAPI de C has a net margin of 8.08% compared to USANA Health Sciences' net margin of -2.34%. Betterware de Mexico SAPI de C's return on equity of 70.20% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Betterware de Mexico SAPI de C8.08% 70.20% 10.82%
USANA Health Sciences -2.34%3.56%2.62%

12.7% of Betterware de Mexico SAPI de C shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Betterware de Mexico SAPI de C has higher earnings, but lower revenue than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Betterware de Mexico SAPI de C$744M0.86$55.37M$1.958.32
USANA Health Sciences$925.26M0.26$10.76M-$1.15N/A

In the previous week, Betterware de Mexico SAPI de C had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Betterware de Mexico SAPI de C and 0 mentions for USANA Health Sciences. Betterware de Mexico SAPI de C's average media sentiment score of 1.42 beat USANA Health Sciences' score of 0.00 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the media.

Company Overall Sentiment
Betterware de Mexico SAPI de C Positive
USANA Health Sciences Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Betterware de Mexico SAPI de C
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Betterware de Mexico SAPI de C has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

Summary

Betterware de Mexico SAPI de C beats USANA Health Sciences on 13 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Honest?

USANA Health Sciences (NYSE:USNA) and Honest (NASDAQ:HNST) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

In the previous week, Honest had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Honest and 0 mentions for USANA Health Sciences. Honest's average media sentiment score of 0.79 beat USANA Health Sciences' score of 0.00 indicating that Honest is being referred to more favorably in the news media.

Company Overall Sentiment
USANA Health Sciences Neutral
Honest Positive

USANA Health Sciences has higher revenue and earnings than Honest. USANA Health Sciences is trading at a lower price-to-earnings ratio than Honest, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.26$10.76M-$1.15N/A
Honest$371.32M1.30-$15.69M$0.696.43

USANA Health Sciences has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Honest has a beta of 2.48, meaning that its stock price is 148% more volatile than the broader market.

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 45.5% of Honest shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by insiders. Comparatively, 9.4% of Honest shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Honest has a consensus price target of $5.43, indicating a potential upside of 22.18%. Given Honest's stronger consensus rating and higher probable upside, analysts plainly believe Honest is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Honest
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
2.56

Honest has a net margin of 23.47% compared to USANA Health Sciences' net margin of -2.34%. Honest's return on equity of 5.10% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences-2.34% 3.56% 2.62%
Honest 23.47%5.10%4.03%

Summary

Honest beats USANA Health Sciences on 14 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Prenetics Global presently has a consensus price target of $36.17, indicating a potential upside of 310.98%. Given Prenetics Global's stronger consensus rating and higher possible upside, equities analysts clearly believe Prenetics Global is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.88
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

USANA Health Sciences has higher revenue and earnings than Prenetics Global. USANA Health Sciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39M1.61-$37.71M-$4.16N/A
USANA Health Sciences$925.26M0.26$10.76M-$1.15N/A

In the previous week, Prenetics Global had 43 more articles in the media than USANA Health Sciences. MarketBeat recorded 43 mentions for Prenetics Global and 0 mentions for USANA Health Sciences. USANA Health Sciences' average media sentiment score of 0.00 beat Prenetics Global's score of -0.09 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Prenetics Global Neutral
USANA Health Sciences Neutral

Prenetics Global has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

USANA Health Sciences has a net margin of -2.34% compared to Prenetics Global's net margin of -47.43%. USANA Health Sciences' return on equity of 3.56% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-47.43% -21.41% -15.56%
USANA Health Sciences -2.34%3.56%2.62%

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 7.8% of Prenetics Global shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

USANA Health Sciences beats Prenetics Global on 9 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Nu Skin Enterprises?

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.26$10.76M-$1.15N/A
Nu Skin Enterprises$1.49B0.12$160.20M-$4.83N/A

USANA Health Sciences has a net margin of -2.34% compared to Nu Skin Enterprises' net margin of -17.72%. Nu Skin Enterprises' return on equity of 5.35% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences-2.34% 3.56% 2.62%
Nu Skin Enterprises -17.72%5.35%2.88%

USANA Health Sciences has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

In the previous week, USANA Health Sciences' average media sentiment score of 0.00 equaled Nu Skin Enterprises'average media sentiment score.

Company Overall Sentiment
USANA Health Sciences Neutral
Nu Skin Enterprises Neutral

Summary

Nu Skin Enterprises beats USANA Health Sciences on 9 of the 12 factors compared between the two stocks.

How does USANA Health Sciences compare to Nature's Sunshine Products?

Nature's Sunshine Products (NASDAQ:NATR) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Nature's Sunshine Products has a net margin of 3.05% compared to USANA Health Sciences' net margin of -2.34%. Nature's Sunshine Products' return on equity of 10.42% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Nature's Sunshine Products3.05% 10.42% 6.64%
USANA Health Sciences -2.34%3.56%2.62%

Nature's Sunshine Products has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

Nature's Sunshine Products has higher earnings, but lower revenue than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nature's Sunshine Products$480.14M0.37$19.52M$0.8212.41
USANA Health Sciences$925.26M0.26$10.76M-$1.15N/A

In the previous week, Nature's Sunshine Products had 3 more articles in the media than USANA Health Sciences. MarketBeat recorded 3 mentions for Nature's Sunshine Products and 0 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 1.04 beat USANA Health Sciences' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company Overall Sentiment
Nature's Sunshine Products Positive
USANA Health Sciences Neutral

Nature's Sunshine Products currently has a consensus price target of $25.00, indicating a potential upside of 145.58%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, research analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nature's Sunshine Products
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
USANA Health Sciences
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Nature's Sunshine Products beats USANA Health Sciences on 15 of the 16 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

USNA vs. The Competition

MetricUSANA Health SciencesPersonal Care Products IndustryConsumer Staples SectorNYSE Exchange
Market Cap$250.34M$27.00B$17.50B$21.75B
Dividend YieldN/A6.18%3.21%3.83%
P/E Ratio-11.2927.4725.3127.90
Price / Sales0.261.961.693.51
Price / Cash3.2825.7016.4415.54
Price / Book0.462.643.073.45
Net Income$10.76M$1.19B$846.84M$1.07B
1 Month Performance-8.70%-10.05%-1.65%-7.18%
1 Year Performance-33.94%-17.74%-3.61%0.54%

USANA Health Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
USNA
USANA Health Sciences
0.9457 of 5 stars
$12.98
-1.4%
N/A-30.7%$250.34M$925.26MN/A1,570
BWMX
Betterware de Mexico SAPI de C
4.5013 of 5 stars
$16.62
-2.5%
N/A+19.5%$652.25M$16.31B8.472,441
HNST
Honest
4.0718 of 5 stars
$5.14
-0.7%
$5.43
+5.6%
+75.5%$568.56M$371.32M7.49174
PRE
Prenetics Global
4.52 of 5 stars
$18.36
+4.6%
$37.17
+102.4%
-31.7%$306.36M$92.39MN/A98
NUS
Nu Skin Enterprises
1.3791 of 5 stars
$4.21
-1.6%
N/A-59.8%$204.65M$1.49BN/A2,800

Related Companies and Tools


This page (NYSE:USNA) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners